Effect of flaxseed gum on reduction of blood glucose and cholesterol in type 2 diabetic patients

International Journal of Food Sciences and Nutrition

Volumn 60, Issue SUPPL. 6, 2009, Pages 126-136

  Thakur, Goutam ^a   Mitra, Analava ^a   Pal, Kunal ^b   Rousseau, Dérick ^c  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

^b NATIONAL INSTITUTE OF TECHNOLOGY   (India)

^c RYERSON UNIVERSITY   (Canada)

Author keywords

Fasting blood sugar; Flaxseed gum; Low density lipoprotein; Total cholesterol; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT GUM;

ARTICLE; AYURVEDA; BLOOD; BREAD; CHEMISTRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DIET THERAPY; ECONOMICS; ELEMENTAL DIET; ETHNOLOGY; FEMALE; FLAX; FOOD INDUSTRY; FOOD PREFERENCE; HUMAN; HYPERCHOLESTEROLEMIA; INDIA; INDUSTRIAL WASTE; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MUCILAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; PLANT SEED; RANDOMIZED CONTROLLED TRIAL;

ANTICHOLESTEREMIC AGENTS; BREAD; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIET; FEMALE; FLAX; FOOD PREFERENCES; FOOD, FORMULATED; FOOD-PROCESSING INDUSTRY; HUMANS; HYPERCHOLESTEROLEMIA; HYPOGLYCEMIC AGENTS; INDIA; INDUSTRIAL WASTE; MALE; MEDICINE, AYURVEDIC; MIDDLE AGED; PILOT PROJECTS; PLANT GUMS; PLANT MUCILAGE; SEEDS;

LINUM USITATISSIMUM; TRITICUM AESTIVUM;

EID: 77951473140     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.1080/09637480903022735     Document Type: Article

References (43)

1. American Diabetes Association. 2006. Diagnosis and classification of diabetes mellitus. Diabetes Care 29(suppl 1):S43-S48.
2. Bhathena SJ, Ali AA, Haudenschild C, Latham P, Ranich T, Mohamed AI, Hansen CT, Velasquez MT. 2003. Dietary flaxseed meal is more protective than soy protein concentrate against hypertriglyceridemia and steatosis of the liver in an animal model of obesity. J Am Coll Nutr 22:157-164. (Pubitemid 36417829)
3. Bjork S, Kapur A, King H, Nair J, Ramachandran A. 2003. Global policy: Aspects of diabetes in India. Health Policy 66:61-72. (Pubitemid 37123024)
4. Boehringer Mannheim. 1983. Instruction sheets for manual assays. Mannheim: GmbH Diagnostica.
5. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. 2000. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23(1):57-63.
6. Brenelli SL, Campos SD, Saad MJ. 1997. Viscosity of gums in vitro and their ability to reduce postprandial hyperglycaemia in normal subjects. Braz J Med Biol Res 30(12):1437-1440.
7. Brown NJ, Worlding J, Rumsey RD, Read NW. 1988. The effect of guar gum on the distribution of a radio labelled meal in the gastrointestinal tract of the rat. Br J Nutr 59(2):223-231.
8. Cintra DEC, Costa AGV, Peluzio MDC, Matta SLP, Silva MTC, Costa NMB. 2006. Lipid profile of rats fed high-fat diets based on flaxseed, peanut, trout, or chicken skin. Nutrition 22:197-205.
9. Cunnane SC, Ganguli S, Menard C, Liede AC, Hamadeh MJ, Chen ZY, Wolever T MS, Jenkins DJA. 1993. High alpha-linolenic acid flaxseed (Linum usitatissimum): Some nutritional properties in humans. Br J Nutr 69:443.
10. Cunnane SC, Hamadeh MJ, Lide ACA, Thompson LU, Wolever TMS, Jenkins DJA. 1995. Nutritional attributes of traditional flax seed in healthy young adults. Am J Clin Nutr 61:62-68.
11. Dahl WJ, Lockert EA, Cammer AL, Whiting SJ. 2005. Effects of flax fibre on laxation and glycemic response in healthy volunteers. J Med Food 8(4):508-511.
12. Dodin S, Lemay A, Jacques H, Legare F, Forest JC, Masse B. 2005. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: A randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90(3):1390-1397.
13. Dugani A, Auzzi A, Naas F, Megwez S. 2008. Effects of the oil and mucilage from flaxseed (Linum usitatissimum) on gastric lesions induced by ethanol in rats. Libyan J Med AOP:080612.
14. Elston RC, Johnson WD. 2008. Basic biostatistics for geneticists and epidemiologists. Chichester, West Sussex, UK: John Wiley and Sons.
15. Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 18:499-502.
16. Frost G, Keogh B, Smith D, Akinsanya K, Leeds A. 1996. The effect of low-glycemic carbohydrate on insulin and glucose response in vivo and in vitro in patients with coronary heart disease. Metabolism 45:669-672.
17. Frost G, Leeds A, Trew G, Margara R, Doruhorst A. 1998. Insulin sensitivity in women at risk of coronary heart disease and the effect of a low glycemic diet. Metabolism 47:1245-1251.
18. Genuth S. 2008. The UKPDS and its global impact. Diabet Med 25:57-62.
19. Glore SR, Treeck DV, Allen W, Knehans AW, Guild M. 1994. Soluble fibre and serum lipids: a literature review. J Am Diet Assoc 94(4):425-436.
20. Groop PH, Aro A, Stenman S, Groop L. 1993. Long-term effects of guar gum in subjects with non-insulindependent diabetes mellitus. Am J Clin Nutr 58(4):513-518.
21. Hirsch A, Bartholome C, Volmer T. 2000. Dimension of quality of life in people with non-insulin-dependent diabetes. Qual Life Res 9:207-218.
22. Hossain P, Kawar B, Nahas ME. 2007. Obesity and diabetes in the developing world*a growing challenge. N Engl J Med 356:213-215.
23. Indian Council of Medical Research. 2000. Ethical guidelines for biomedical research on human subjects. New Delhi: ICMR. p 32.
24. International Diabetes Federation. 2007. Facts and figures, prevalence. Available online at: www.idf.org (25 September 2007).
25. Jenkins DJ, Wolever TM, Collier GR, Ocana A, Rao AV, Buckley G, Lam Y, Mayer A, Thompson LU. 1987. Metabolic effects of a low-glycemic-index diet. Am J Clin Nutr 46:968-975.
26. Jenkins DJ, Wolever TM, Buckley G, Lam KY, Giudici S, Kalmusky J, Jenkins AL, Patten RL, Bird J, Wong GS, Josse RG. 1988. Low-glycemic-index starchy foods in the diabetic diet. Am J Clin Nutr 48:248-254.
27. Jhamb R, Gaiha M, Chakravarti AL, Daga MK. 2005. Insulin resistance/hyperinsulinaemia as a risk factor for common carotid artery intima media thickness in essential hypertension. J Indian Acad Clinical Med 6(2):122-128.
28. Leeds AR. 1985. Dietary fibre perspectives*Reviews and bibliography. London: John Libbey.
29. Lemay A, Dodin S, Kadri N, Jacques H, Forest JC. 2002. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 100(3):495-504.
30. Mazza G, Biliaderis CG. 1989. Functional properties of flaxseed mucilage. J Food Sci 54(5):1302-1305.
31. Mandasescu S, Mocanu V, Dascalita AM, Haliga R, Nestian I, Stiff PA, Luca V. 2005. Flaxseed supplementation in hyperlipidemic patients. Rev Med Chir Soc Med Nat Iasi 109(3):502-506.
32. McIntosh A, Hutchinson A, Home PD, Brown F, Bruce A, Damerell A, Davis R, Field R, Frost G, Marshall S, et al. 2001. Clinical guidelines and evidence review for type 2 diabetes: Management of blood glucose. Sheffield: ScHARR, University of Sheffield.
33. Mitra A. 2002.Control of type 2 diabetes by unconventional methods. PhD dissertation, Chemical Engineering Department, IIT Kharagpur.
34. Mitra A, Bhattacharya DP, Som NK. 2005. A review on past studies regarding advantages of flaxseed oil and flaxseed products in health of rural Indian diabetics. Indian J Endocrinol Metab 7(2):90-96.
35. Mitra A, Bhattacharya D, Roy S. 2007. Dietary influence on type 2 Diabetes (NIDDM). Int J Human Ecol 21(2):139-147.
36. Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saroja R. 2001. Intra-urban differences in the prevalence of the metabolic syndrome in southern India*The Chennai Urban Population study (CUPS No. 4). Diabetic Med 18(4):280-287.
37. Paschos GK, Zampelas A, Panagiotakos DB, Katsiougiannis S, Griffin BA, Vasilios Votteas V, Skopouli FN. 2007. Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men. Eur J Nutr 46:315-320.
38. Pellizzon MA, Billheimer JT, Bloedon LT, Szapary PO, Rader DJ. 2007. Flaxseed reduces plasma cholesterol levels in hypercholesterolemic mouse models. J Am Coll Nutr 26:66-75.
39. Poznanski N, Poznanski WJ. 1969. Laboratory application of the dextran-coated-charcoal radioimmunoassay of insulin. Clin Chem 15:908-918.
40. Prasad K. 2007. A study on regression of hypercholesterolemic atherosclerosis in rabbits by flax lignan complex. J Cardiovasc Pharmacol Ther 12:304-313.
41. Trease G, Evans W. 1980. Drugs of biological origin. 11th ed. London: Bailliere Tindall. 741:319-320.
42. Wild S, Roglic G, Green A, Sicree R, King H. 2004. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053.
43. Wu SY, Sainfort F, Tomar RH, Tollios JL, Fryback DG, Klein R. 1998. Development and application of a model to estimate the impact of type 1 diabetes on health related quality of life. Diabetes Care 21: 725-731.